Watch This Space: Glenmark-SaNOtize’s COVID-19 Nasal Spray Debuts In India

Glenmark's partnered nitric oxide nasal spray for COVID-19 debuts in India at about $11, with the firm spotlighting the reduction in viral load with the product and potential to cut the chain of transmission. But more competition appears to be in the wings.

herd immunity
Can Glenmark's partnered nitric oxide nasal spray gain traction? • Source: Alamy

Canada-based biotech firm SaNOtize Research and Development Corporation’s novel Nitric Oxide Nasal Spray (NONS) for COVID-19 has hit the Indian market, with the firm seemingly eyeing opportunities in other parts of Asia as well, including Japan.

The India launch comes after local partner Glenmark Pharmaceuticals Limited received a go-ahead for the product (branded FabiSpray) from...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip